Filing Details

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3) AEGERION PHARMACEUTICALS INC -------------------------------------------------------------------------------- (Name of Issuer) Common -------------------------------------------------------------------------------- (Title of Class of Securities) 00767E102 -------------------------------------------------------------------------------- (CUSIP Number) December 31, 2016 -------------------------------------------------------------------------------- (Date of Event Which Requires Filing Of This Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: (X) Rule 13d-1(b) ( ) Rule 13d-1(c) ( ) Rule 13d-1(d) 13G CUSIP 00767E102 -------------------------------------------------------------------------------- 1. Name of reporting person S.S. or I.R.S. identification no. of above person Putnam Investments, LLC. d/b/a/ Putnam Investments 26-1080669 -------------------------------------------------------------------------------- 2. Check the appropriate box if a member of a group (a) ( ) (b) ( ) -------------------------------------------------------------------------------- 3. SEC use only -------------------------------------------------------------------------------- 4. Citizenship or place of organization Delaware -------------------------------------------------------------------------------- Number of shares beneficially owned by each reporting person with: 5. Sole Voting Power NONE ------------------------ 6. Shared Voting Power NONE ------------------------ 7. Sole Dispositive NONE ------------------------ 8. Shared Dispositive NONE -------------------------------------------------------------------------------- 9. Aggregate amount beneficially owned by each reporting person NONE -------------------------------------------------------------------------------- 10. Check box if the aggregate amount in row (9) excludes certain shares ( ) -------------------------------------------------------------------------------- 11. Percent of class represented by amount in row 9 NONE -------------------------------------------------------------------------------- 12. Type of Reporting person HC --------------------------------------------------------------------------------

13G CUSIP 00767E102 -------------------------------------------------------------------------------- 1. Name of reporting person S.S. or I.R.S. identification no. of above person The Putnam Advisory Company, LLC. 04-3543039 -------------------------------------------------------------------------------- 2. Check the appropriate box if a member of a group (a) ( ) (b) ( ) -------------------------------------------------------------------------------- 3. SEC use only -------------------------------------------------------------------------------- 4. Citizenship or place of organization Delaware -------------------------------------------------------------------------------- Number of shares beneficially owned by each reporting person with: 5. Sole Voting Power NONE ------------------------ 6. Shared Voting Power NONE ------------------------ 7. Sole Dispositive NONE ------------------------ 8. Shared Dispositive NONE -------------------------------------------------------------------------------- 9. Aggregate amount beneficially owned by each reporting person NONE -------------------------------------------------------------------------------- 10. Check box if the aggregate amount in row (9) excludes certain shares ( ) -------------------------------------------------------------------------------- 11. Percent of class represented by amount in row 9 NONE -------------------------------------------------------------------------------- 12. Type of Reporting person IA --------------------------------------------------------------------------------Item 1(a) Name of Issuer: AEGERION PHARMACEUTICALS INC -------------------------------------------------------------------------------- Item 1(b) Address of Issuer's Principal Executive Offices: One Main Street Suite 800 Cambridge, MA 02142 -------------------------------------------------------------------------------- Item 2(a) Item 2(b) Name of Person Filing: Address or principal business office or, if none, residence: Putnam Investments, LLC d/b/a One Post Office Square Putnam Investments ("PI") Boston, Massachusetts 02109 on behalf of itself and: Putnam Investment Management One Post Office Square Management, LLC. ("PIM") Boston, Massachusetts 02109 The Putnam Advisory One Post Office Square Company, LLC. ("PAC") Boston, Massachusetts 02109 -------------------------------------------------------------------------------- Item 2(c) Citizenship: PI, PIM and PAC are limited liability companies organized under Delaware law. -------------------------------------------------------------------------------- Item 2(d) Title of Class of Securities: Common -------------------------------------------------------------------------------- Item 2(e) Cusip Number: 00767E102 --------------------------------------------------------------------------------Item 3. If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a)( ) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); (b)( ) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); (c)( ) Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); (d)( ) Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8); (e)(X) An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); (f)( ) An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); (g)(X) A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); (h)( ) A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i)( ) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j)( ) A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J); (k)( ) Group, in accordance with 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____________________________Item 4. Ownership PIM* + PAC* = PI** ---- ---- ---- (a) Amount Beneficially NONE NONE NONE Owned: (b) Percent of Class: NONE NONE NONE (c) Number of shares as to which the person has: (1) Sole power to vote NONE NONE NONE or to direct the vote; (but see Item 7) (2) Shared power to vote NONE NONE NONE or to direct the vote; (but see Item 7) (3) Sole power to dispose or to direct the NONE NONE NONE disposition of; (but see Item 7) (4) Shared power to dispose or to direct NONE NONE NONE the disposition of; (but see Item 7) * Investment adviser subsidiary of PI ** Parent company to PIM and PACItem 5. Ownership of 5 Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following (X) Item 6. Ownership of More than Five/Ten Percent on Behalf of Another Person: Clients of or the persons filing this Schedule 13G have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported on this Schedule 13G. Unless otherwise indicated by the persons filing this Schedule 13G, no person's interest relates to more than five percent of the class of securities. Securities reported on this Schedule 13G as being beneficially owned by PI consist of securities beneficially owned by subsidiaries of PI which are registered investment advisers, which in turn include securities beneficially owned by clients of such investment advisers, which clients may include investment companies registered under the Investment Company Act and/or employee benefit plans, pension funds, endowment funds or other institutional clients. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company PI, wholly owns two registered investment advisers: Putnam Investment Management, LLC, which is the investment adviser to the Putnam family of mutual funds and the Putnam Advisory Company, LLC, which is the investment adviser to Putnam's institutional clients. Both subsidiaries have dispositive power over the shares as investment managers. In the case of shares held by the Putnam mutual funds managed by Putnam Investment Management, LLC, the mutual funds, through their boards of trustees, have voting power. Unless otherwise indicated, The Putnam Advisory Company, LLC has sole voting power over the shares held by its institutional clients. Pursuant to Rule 13d-4, PI declares that the filing of this Schedule 13G shall not be deemed an admission for the purposes of Section 13(d) or 13(g) that it is the beneficial owner of any securities covered by this Schedule 13G, and further states that it does not have any power to vote or dispose of, or direct the voting or disposition of, any of the securities covered by this Schedule 13G. Item 8. Identification and Classification of Members of the Group: Not applicable. Item 9. Notice of Dissolution of Group: Not applicable